Positive Concordance between Commercially Available SARS-CoV-2 Rapid Antigen Test and RT-PCR during the Omicron Wave in Thailand Samadhi
Patamatamkul¹, Ploysai Rujkorakarn²
Affiliation : ¹ Department of Medicine, Suddhavej Hospital, Faculty of Medicine, Mahasarakham University, Mahasarakham, Thailandม ² Department of Ophthalmology, Suddhavej Hospital, Faculty of Medicine, Mahasarakham University, Mahasarakham, Thailand
Background: Rapid SARS-CoV-2 antigen tests are widely used throughout the world. False positive antigen tests have been reported.
Objective: To evaluate the positive percentage concordance (PPC) between a rapid antigen test and the nucleic acid amplification testing (NAAT).
Materials and Methods: The present study was a retrospective laboratory-based study on rapid antigen test-positive nasopharyngeal or throat swabs sent for confirmation by real-time reverse transcriptase polymerase chain reaction (rRT-PCR) between January 1 and April 8, 2022. The primary outcome was a PPC between antigen-positive samples and PCR-positive samples.
Results: Of the 22,808 samples received, there were 3,656 or 16.04% of the samples with documented positive rapid antigen tests sent for confirmation by rRT-PCR. Overall, PPC was 92.67%, 95% CI 91.82 to 93.51. A higher PPC was found during the BA.2-dominant Omicron variant period at 96.08% (95% CI 95.2 to 96.95).
Conclusion: The PPC between the rapid antigen test used and rRT-PCR was very high, especially during the BA.2-dominant period.
Received 13 June 2022 | Revised 15 August 2022 | Accepted 24 August 2022
DOI: 10.35755/jmedassocthai.2022.10.13681
Keywords : Rapid antigen test; Omicron; rT-PCR; Positive percentage concordance
